Home Medicine Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma
Article
Licensed
Unlicensed Requires Authentication

Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma

  • Weijie Chen , Fengfeng Cai , Bei Zhang and Xiao Yan Zhong EMAIL logo
Published/Copyright: October 31, 2011

Abstract

Background: Circulating cell-free (ccf) DNA in blood has been suggested as a potential biomarker in many conditions regarding early diagnosis and prognosis. However, misdiagnosis can result due to the limited DNA resources in Biobank’s plasma samples or insufficient DNA targets from a predominant DNA background in genetic tests. This study explored several strategies for an efficient DNA extraction to increase DNA amount from limited plasma input.

Methods: Ccf plasma DNA was extracted with three different methods, a phenol-chloroform-isoamylalcohol (PCI) method, a High Pure PCR Template Preparation Kit method and a method used for single cell PCR in this group. Subsequently, the total DNA was measured by Nanodrop and the genome equivalents (GE) of the GAPDH housekeeping gene and MTATP 8 gene were measured using a multiplex real-time quantitative PCR for the quantitative assessment of nDNA and mtDNA.

Results: Instead of 400–800 μL (routine input in the laboratory), 50 μLof plasma input enabled the extraction of ccf DNA sufficient for quantitative analysis. Using the PCI method and the kit method, both nDNA and mtDNA could be successfully detected in plasma samples, but nDNA extracted using protocol for single cell PCR was not detectable in 25% of plasma samples. In comparison to the other two methods, the PCI method showed lower DNA purity, but higher concentrations and more GE of nDNA and mtDNA.

Conclusions: The PCI method was more efficient than the other two methods in the extraction of ccf DNA in plasma. Limited plasma is available for ccf DNA analysis.


Corresponding author: Xiao Yan Zhong, Laboratory for Gynecological Oncology, Department of Biomedicine, University Women’s Hospital, University of Basel, Hebelstr, 20, 4031 Basel, Switzerland Phone: +41 612 659 248, Fax: +41 612 659 399

Received: 2011-7-7
Accepted: 2011-10-3
Published Online: 2011-10-31
Published in Print: 2012-02-01

©2012 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Editorials
  2. Biological variation and reference change values: an essential piece of the puzzle of laboratory testing
  3. Copeptin for acute coronary syndrome: diamond or decoy?
  4. Reviews
  5. Gold nanoparticles in the clinical laboratory: principles of preparation and applications
  6. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)
  7. Mini Review
  8. From “Clinical Proteomics” to “Clinical Chemistry Proteomics”: considerations using quantitative mass-spectrometry as a model approach
  9. Opinion Paper
  10. Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients: the case of copeptin
  11. Perspectives
  12. Do genome-wide association scans have potential for translation?
  13. Genetics and Molecular Diagnostics
  14. Strategies of reducing input sample volume for extracting circulating cell-free nuclear DNA and mitochondrial DNA in plasma
  15. Evaluation of Maxwell® 16 for automated DNA extraction from whole blood and formalin-fixed paraffin embedded (FFPE) tissue
  16. Screening for mutations in the α-globin genes leading to abnormal hemoglobin variants with high resolution melting analysis
  17. Alternative methods to a TaqMan assay to detect a tri-allelic single nucleotide polymorphism rs757210 in the HNF1β gene
  18. Gender- and obesity-specific effect of apolipoprotein C3 gene (APOC3) –482C>T polymorphism on triglyceride concentration in Turkish adults
  19. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients
  20. Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods
  21. Functional polymorphisms of GSTA1 and GSTO2 genes associated with asthma in Italian children
  22. General Clinical Chemistry and Laboratory Medicine
  23. Optimisation of whole blood and plasma manganese assay by ICP-MS without use of a collision cell
  24. Quantitative performance of antibody array technology in a prenatal screening setting
  25. A comparison of the acute effects of calcium and strontium ranelate on the serum marker of bone resorption
  26. A new dot immunoassay for simultaneous detection of celiac specific antibodies and IgA-deficiency
  27. Preferentially immunoglobulin (IgG) subclasses production in primary Sjögren’s syndrome patients
  28. Development of control material for hemoglobin analysis
  29. Evaluation of nucleated red blood cells in the peripheral blood of hematological diseases
  30. The effect of hematocrit on the results of measurements using glucose meters based on different techniques
  31. Lupus anticoagulant testing: analyzing fresh samples after a single centrifugation and after a 6–8 h delay
  32. Pseudoeosinophilia of synovial fluid is caused by crystals mimicking the distinct light scattering fractions of eosinophilic granules
  33. The effect of acidification and oxalate concentration on urine calcium measurements in EQAS materials and patient samples
  34. Cancer Diagnostics
  35. The multi-cancer marker, rs6983267, located at region 3 of chromosome 8q24, is associated with prostate cancer in Greek patients but does not contribute to the aggressiveness of the disease
  36. Cardiovascular Diseases
  37. Heart type fatty acid binding protein in relation to pharmacologic scintigraphy in coronary artery disease
  38. Effects of fibrates on C-reactive protein concentrations: a meta-analysis of randomized controlled trials
  39. Letters to the Editor
  40. Comparison of Bio-Plex measurements with standard techniques
  41. Interference of hemoglobin (Hb) Las Palmas with HPLC measurement of HbA1c in 87 patients
  42. False-positive calcitonin results in patients with benign goiter
  43. Erratum
  44. Heterophilic antibody interference in commercial immunoassays; a screening study using paired native and pre-blocked sera
  45. Congress Abstracts
  46. Advances and Controversies in B-Vitamins and Choline
  47. Prelims
Downloaded on 11.2.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm.2011.773/html
Scroll to top button